Abstract
Abstract Eleutherococcus senticosus (Rupt. & Maxim.) Maxim is a shrub plant, it is the traditional medicine which is used to treat numerous diseases such as rheumatism, diabetes and hepatitis. In this study, a new furofuran lignan 1/2,5/6-trans-2-(3”,4”-methylenedioxyphenyl)-6-(3',4'-methylenedioxyphenyl)-8-oxo-3,7-dioxabicyclo[3.3.0]octane (1) and two new neolignans cis-7,8-dihydro-8-acetylmethyl-7-(4-hydroxy-3,5'-methoxyphenyl)-1'-benzofuranpropanol (5) and 7,8-erythro-5,9-dihydroxy-4,3'-dimethoxy-5,8'-oxyneolign-1'-propanol (8) together with seven known compounds (2-4, 6, 7, 9, 10) were obtained from the EtOAc-soluble extract of Eleutherococcus senticosus. Their structures were determined by analysis of basis of spectroscopic and physicochemical. All the compounds were evaluated for in vitro inhibitory activity against DGAT1 and DGAT2. The in vitro inhibitory activity of all isolated were found to exhibited significant selective inhibitory activity on DGAT1 with IC50 values ranging from 78.8 ± 1.0–132.1 ± 1.1 μM.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
